Q1 2026 · 13F-HR
Yiheng Capital Management, L.P.holdings as filed
Filed 2026-05-15 · accession 0001420506-26-001131
$230.7M
Reported value
24
Positions
2026-03-31
Period end
The Brief · Yiheng Capital Management, L.P. · Q1 2026
AI · grounded in 13F
Yiheng Capital Management, L.P. closed its position in ALAB, reducing exposure by $237.48M. The fund also exited positions in VSAT and ULS, totaling $15.7M and $11.83M respectively. To offset these sales, the fund established new positions in HNGE for $11.45M and BILL for $8.53M. Additionally, the fund increased its stake in TAL by 145.52%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 65487X102 | NOAH | NOAH HLDGS LTD | $66.5M | 28.8% | 6,717,351 | Common | SOLE |
| 647581206 | EDU | NEW ORIENTAL ED & TECHNOLOGY | $21.3M | 9.24% | 376,551 | Common | SOLE |
| 47215P106 | JD | JD.COM INC | $17.4M | 7.53% | 587,513 | Common | SOLE |
| 090040106 | BILI | BILIBILI INC | $16.7M | 7.24% | 739,915 | Common | SOLE |
| 44332N106 | HTHT | H WORLD GROUP LTD | $16.3M | 7.05% | 323,371 | Common | SOLE |
| 00138L108 | RERE | ATRENEW INC | $14.8M | 6.43% | 3,163,117 | Common | SOLE |
| 433313103 | HNGE | HINGE HEALTH INC | $11.4M | 4.96% | 296,853 | Common | SOLE |
| 874080104 | TAL | TAL ED GROUP | $8.6M | 3.74% | 759,240 | Common | SOLE |
| 090043100 | BILL | BILL HOLDINGS INC | $8.5M | 3.70% | 222,820 | Common | SOLE |
| 82728C102 | SVCO | SILVACO GROUP INC | $7.8M | 3.36% | 1,096,282 | Common | SOLE |
| 732908108 | PONY | PONY AI INC | $6.2M | 2.67% | 653,215 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $6.1M | 2.65% | 73,440 | Common | SOLE |
| 46591M109 | JOYY | JOYY INC | $5.0M | 2.17% | 85,583 | Common | SOLE |
| 89677Q107 | TCOM | TRIP COM GROUP LTD | $4.4M | 1.90% | 88,112 | Common | SOLE |
| 35969L108 | YMM | FULL TRUCK ALLIANCE CO LTD | $4.3M | 1.85% | 513,248 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $4.1M | 1.77% | 208,735 | Common | SOLE |
| 23306J309 | DBVT | DBV TECHNOLOGIES S A | $3.6M | 1.54% | 170,142 | Common | SOLE |
| 00851L103 | API | AGORA INC | $2.6M | 1.11% | 725,795 | Common | SOLE |
| 985194208 | YSG | YATSEN HLDG LTD | $2.5M | 1.07% | 797,866 | Common | SOLE |
| 98945L204 | ZEPP | ZEPP HEALTH CORPORATION | $689,885 | 0.30% | 57,731 | Common | SOLE |
| 702712209 | PASG | PASSAGE BIO INC | $675,861 | 0.29% | 86,097 | Common | SOLE |
| M2197Q107 | CLBT | CELLEBRITE DI LTD | $633,880 | 0.27% | 46,000 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $503,433 | 0.22% | 21,126 | Common | SOLE |
| 89977P106 | TOUR | TUNIU CORP | $242,116 | 0.10% | 314,437 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.